Clinical Trial Update: A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS) [Phase 2]

View source ↗

Summary

A Phase 2 pharmacokinetics/pharmacodynamics and safety/tolerability trial of Fenebrutinib in children and adolescents with Relapsing Multiple Sclerosis is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Fenebrutinib (Fenebrutinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Relapsing Multiple Sclerosis | Phase 2 | Status: RECRUITING